rs747144655

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_017882.3(CLN6):​c.*312C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000614 in 431,646 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00059 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00063 ( 0 hom. )

Consequence

CLN6
NM_017882.3 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.783

Publications

0 publications found
Variant links:
Genes affected
CLN6 (HGNC:2077): (CLN6 transmembrane ER protein) This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function. [provided by RefSeq, Oct 2008]
CLN6 Gene-Disease associations (from GenCC):
  • ceroid lipofuscinosis, neuronal, 6A
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Laboratory for Molecular Medicine, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P
  • ceroid lipofuscinosis, neuronal, 6B (Kufs type)
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Genomics England PanelApp
  • neuronal ceroid lipofuscinosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_017882.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN6
NM_017882.3
MANE Select
c.*312C>T
3_prime_UTR
Exon 7 of 7NP_060352.1Q9NWW5-1
CLN6
NM_001411068.1
c.*312C>T
3_prime_UTR
Exon 7 of 7NP_001397997.1Q9NWW5-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CLN6
ENST00000249806.11
TSL:1 MANE Select
c.*312C>T
3_prime_UTR
Exon 7 of 7ENSP00000249806.5Q9NWW5-1
ENSG00000260007
ENST00000562767.2
TSL:3
c.84-10200C>T
intron
N/AENSP00000456336.1H3BRN7
CLN6
ENST00000638076.1
TSL:1
n.*851C>T
non_coding_transcript_exon
Exon 7 of 7ENSP00000490373.1A0A0S2Z5D0

Frequencies

GnomAD3 genomes
AF:
0.000592
AC:
90
AN:
152130
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.0219
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000838
Gnomad OTH
AF:
0.000958
GnomAD4 exome
AF:
0.000626
AC:
175
AN:
279398
Hom.:
0
Cov.:
0
AF XY:
0.000603
AC XY:
90
AN XY:
149366
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
8258
American (AMR)
AF:
0.000616
AC:
8
AN:
12996
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8052
East Asian (EAS)
AF:
0.00
AC:
0
AN:
15498
South Asian (SAS)
AF:
0.0000236
AC:
1
AN:
42324
European-Finnish (FIN)
AF:
0.000228
AC:
3
AN:
13148
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
1122
European-Non Finnish (NFE)
AF:
0.000921
AC:
150
AN:
162876
Other (OTH)
AF:
0.000860
AC:
13
AN:
15124
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
10
20
31
41
51
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000591
AC:
90
AN:
152248
Hom.:
1
Cov.:
33
AF XY:
0.000604
AC XY:
45
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.000193
AC:
8
AN:
41540
American (AMR)
AF:
0.000131
AC:
2
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.0000942
AC:
1
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000838
AC:
57
AN:
68000
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000212
Hom.:
0
Bravo
AF:
0.000567

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Neuronal ceroid lipofuscinosis (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.36
DANN
Benign
0.54
PhyloP100
-0.78

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747144655; hg19: chr15-68500166; API